CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 62 filers reported holding CYTOSORBENTS CORP in Q3 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $151,861 | +134290.3% | 42,301 | -8.1% | 0.05% | +15.6% |
| Q1 2023 | $113 | +76.6% | 46,050 | +11.8% | 0.04% | +73.1% |
| Q4 2022 | $64 | -99.9% | 41,200 | -2.4% | 0.03% | -21.2% |
| Q3 2022 | $57,000 | -38.0% | 42,200 | 0.0% | 0.03% | -36.5% |
| Q2 2022 | $92,000 | +84.0% | 42,200 | +170.5% | 0.05% | +147.6% |
| Q1 2022 | $50,000 | +212.5% | 15,600 | +316.0% | 0.02% | +320.0% |
| Q4 2021 | $16,000 | +60.0% | 3,750 | +212.5% | 0.01% | +25.0% |
| Q3 2021 | $10,000 | -89.1% | 1,200 | -97.2% | 0.00% | -92.3% |
| Q2 2020 | $92,000 | – | 42,200 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 964,141 | $7,829,000 | 1.90% |
| Skylands Capital, LLC | 1,837,541 | $14,921,000 | 1.84% |
| CM Management, LLC | 175,000 | $1,421,000 | 1.06% |
| Soleus Capital Management, L.P. | 800,000 | $6,496,000 | 1.01% |
| Avenir Corp | 1,395,385 | $11,331,000 | 0.95% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 185,000 | $1,502,000 | 0.55% |
| Winning Points Advisors, LLC | 86,200 | $701,000 | 0.51% |
| Granahan Investment Management | 1,154,561 | $9,375,000 | 0.18% |
| SECTORAL ASSET MANAGEMENT INC | 244,660 | $1,987,000 | 0.16% |
| Redmile Group, LLC | 1,044,434 | $8,481,000 | 0.15% |